Physician profile
Mitchell Robert Klement
NPI 1750657904
$17,305.51
in general payments reported to CMS, 2019-2025
13 companies · $1,671 in 2025
The $1,671 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,256 · 2020: $161 · 2021: $1,422 · 2022: $6,896 · 2023: $2,607 · 2024: $292 · 2025: $1,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,143 · Food and Beverage: $1,427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,143.24 |
| Food and Beverage | $1,427.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $4,542.02 | 2021-2025 | Velys |
| Depuy Synthes Products, INC. | $4,228.69 | 2019-2022 | |
| Smith+Nephew, INC. | $3,607.67 | 2019-2023 | Or3o Dual Mobility, Journey, Polarstem |
| Medacta USA, INC. | $1,221.62 | 2024-2025 | Gmk Sphere |
| Pacira Pharmaceuticals Incorporated | $935.27 | 2023 | Iovera, Exparel, Zilretta |
| Stryker Corporation | $811.04 | 2019-2025 | Gamma, Insignia, Mako |
| Total Joint Orthopedics, INC. | $809.04 | 2021-2022 | |
| Depuy Synthes Sales INC. | $611.86 | 2021-2025 | Velys |
| Medtronic USA, INC. | $263.71 | 2019 | |
| Davol INC. | $136.51 | 2021 | |
| Exactech, INC. | $107.87 | 2020 | |
| Sanofi-Aventis U.S. LLC | $17.87 | 2023 | |
| Avanos Medical | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Klement listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.